ALDX
Aldeyra Therapeutics Inc
Price:  
3.49 
USD
Volume:  
269,054.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ALDX Relative Valuation

-639.9%
Upside

As of 2024-02-26, the Relative Valuation of Aldeyra Therapeutics Inc (ALDX) is (18.84) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.49 USD, the upside of Aldeyra Therapeutics Inc based on Relative Valuation is -639.9%.

The range of the Relative Valuation is (17.87) - (20.59) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 23.0x - 27.2x 25.1x
Forward P/E multiples 20.3x - 26.5x 23.4x
Fair Price (17.87) - (20.59) (18.84)
Upside -612.0% - -689.9% -639.9%
3.49 USD
Stock Price
(18.84) USD
Fair Price

ALDX Relative Valuation - Historical P/E Data

Date P/E
2024-02-23 -4.49
2024-02-22 -4.56
2024-02-21 -4.31
2024-02-20 -4.43
2024-02-16 -4.62
2024-02-15 -4.63
2024-02-14 -4.38
2024-02-13 -4.09
2024-02-12 -4.36
2024-02-09 -4.25
2024-02-08 -4.16
2024-02-07 -4.17
2024-02-06 -4.30
2024-02-05 -4.02
2024-02-02 -4.09
2024-02-01 -4.11
2024-01-31 -4.03
2024-01-30 -4.16
2024-01-29 -4.35
2024-01-26 -3.91
2024-01-25 -3.91
2024-01-24 -3.86
2024-01-23 -3.95
2024-01-22 -3.98
2024-01-19 -3.96
2024-01-18 -3.91
2024-01-17 -4.12
2024-01-16 -4.21
2024-01-12 -4.13
2024-01-11 -4.12
2024-01-10 -4.30
2024-01-09 -4.34
2024-01-08 -4.31
2024-01-05 -4.16
2024-01-04 -4.30
2024-01-03 -4.31
2024-01-02 -4.56
2023-12-29 -4.52
2023-12-28 -4.65
2023-12-27 -4.67
2023-12-26 -4.43
2023-12-22 -4.48
2023-12-21 -4.31
2023-12-20 -4.32
2023-12-19 -4.52
2023-12-18 -3.81
2023-12-15 -3.89
2023-12-14 -3.84
2023-12-13 -3.96
2023-12-12 -3.69